BamSEC and AlphaSense Join Forces
Learn More

InMed Pharmaceuticals Inc. – Material Contracts

NASDAQ: INM    
Share price (8/5/26): $1.40    
Market cap (8/5/26): $3.926 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 425 8 pages Amendment No. 1 to the Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 8 pages Amendment No. 1 to the Securities Purchase Agreement
12/34/56
EX-10.35
from S-4 11 pages Mentari Therapeutics, Inc. Warrant to Purchase Common Stock
12/34/56
EX-10.28
from S-4 14 pages Indemnification Agreement
12/34/56
EX-10.27
from S-4 11 pages Mentari Therapeutics, Inc. 2025 Equity Incentive Plan Stock Option Agreement [Incentive Stock Option // Nonstatutory Stock Option]
12/34/56
EX-10.26
from S-4 12 pages Mentari Therapeutics, Inc. 2025 Equity Incentive Plan Restricted Stock Agreement
12/34/56
EX-10.23
from S-4 2 pages First Amendment to the Mentari Therapeutics, Inc. 2025 Equity Incentive Plan
12/34/56
EX-10.22
from S-4 13 pages Mentari Therapeutics, Inc. 2025 Equity Incentive Plan
12/34/56
EX-10.5
from 425 42 pages Securities Purchase Agreement
12/34/56
EX-10.5
from 8-K 42 pages Securities Purchase Agreement
12/34/56
EX-10.4
from 8-K 22 pages Contingent Value Rights Agreement
12/34/56
EX-10.4
from 425 22 pages Contingent Value Rights Agreement
12/34/56
EX-10.3
from 8-K 8 pages Form of Lock-Up Agreement
12/34/56
EX-10.3
from 425 8 pages Form of Lock-Up Agreement
12/34/56
EX-10.2
from 425 18 pages Form of Company Support Agreement
12/34/56
EX-10.2
from 8-K 18 pages Form of Company Support Agreement
12/34/56
EX-10.1
from 8-K 11 pages Form of Parent Support Agreement
12/34/56
EX-10.1
from 425 11 pages Form of Parent Support Agreement
12/34/56
EX-10.1
from 8-K 22 pages Preferred Investment Option InMed Pharmaceuticals Inc
12/34/56
EX-10.2
from 8-K 2 pages Form of Preferred Investment Option Amending Agreement
12/34/56